Abbott Laboratories
ABT
Abbott Laboratories (ABT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Initiated Coverage | Overweight | $120.00 | Oct 7, 2026 |
| Rothschild & Co | Upgraded | Neutral → Buy | $127.00 from $119.00 | Oct 2, 2026 |
| TD Cowen | Maintained | Buy | $135.00 | Sep 8, 2026 |
| TD Cowen | Maintained | Buy | $135.00 from $115.00 | Aug 25, 2026 |
| Wolfe Research | Upgraded | Peer Perform → Outperform | $130.00 | Aug 13, 2026 |
| UBS | Maintained | Buy | $125.00 from $135.00 | Jul 28, 2026 |
| RBC Capital | Maintained | Outperform | $130.00 | Jul 17, 2026 |
| Evercore ISI Group | Maintained | Outperform | $120.00 from $112.00 | Jul 17, 2026 |
| Wells Fargo | Maintained | Overweight | $112.00 from $109.00 | Jul 17, 2026 |
| JP Morgan | Maintained | Overweight | $120.00 from $110.00 | Jul 17, 2026 |
| Piper Sandler | Maintained | Overweight | $118.00 from $115.00 | Jul 17, 2026 |
| Citigroup | Maintained | Buy | $112.00 from $108.00 | Jul 17, 2026 |
| TD Cowen | Maintained | Buy | $115.00 | Jul 17, 2026 |
| BTIG | Maintained | Buy | $134.00 from $131.00 | Jul 17, 2026 |
| Evercore ISI Group | Maintained | Outperform | $112.00 from $120.00 | Jul 6, 2026 |
| Baird | Initiated Coverage | Outperform | $121.00 | Jul 1, 2026 |
| Piper Sandler | Maintained | Overweight | $115.00 | Jun 22, 2026 |
| BTIG | Maintained | Buy | $131.00 | Apr 27, 2026 |
| Barclays | Maintained | Overweight | $143.00 from $144.00 | Apr 20, 2026 |
| Stifel | Maintained | Buy | $120.00 from $145.00 | Apr 17, 2026 |
Frequently asked questions
What is the latest analyst rating on ABT?
On Oct 7, 2026, Barclays initiated coverage of Abbott Laboratories at Overweight with a price target of $120.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.